Pipra Company
PIPRA is a MedTech start-up based in Zurich that is focused on developing innovative products using AI and patient data to prevent, predict, and diagnose delirium. Their flagship product, PIPRA, is an advanced pre-operative risk assessment tool that accurately evaluates a patient's risk of developing postoperative delirium (POD). Delirium is a significant issue in healthcare, affecting 23% of surgical patients over 60, and can lead to adverse outcomes such as increased mortality and higher healthcare costs. PIPRA's AI-driven clinical decision support software helps doctors identify high-risk patients prior to surgery, allowing for effective measures to be implemented and reducing the incidence of delirium by 53%. With a strong advisory board including experts from renowned institutions like Johns Hopkins and Harvard, PIPRA is making strides in improving patient outcomes and reducing healthcare costs.
